Comparable Clinical Outcomes Between Transarterial Chemoembolization or Hepatic Arterial Infusion Chemotherapy Combined with Tyrosine Kinase Inhibitors and PD-1 Inhibitors in Unresectable Hepatocellular Carcinoma

PURPOSE: To compare the treatment efficacy and safety of transarterial chemoembolization (TACE) or hepatic arterial infusion chemotherapy (HAIC) combined with tyrosine kinase inhibitors (TKIs) and programmed cell death protein-1 (PD-1) inhibitors for patients with unresectable hepatocellular carcino...

Descripción completa

Detalles Bibliográficos
Autores principales: Long, Teng, Yang, Zhoutian, Zeng, Huilan, Wu, Weijie, Hu, Zhiwen, Yang, Zhenyun, Hu, Dandan, Zhou, Zhongguo, Chen, Minshan, Zhang, Yaojun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10596130/
https://www.ncbi.nlm.nih.gov/pubmed/37881221
http://dx.doi.org/10.2147/JHC.S436211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10596130/
https://www.ncbi.nlm.nih.gov/pubmed/37881221
http://dx.doi.org/10.2147/JHC.S436211

Ejemplares similares